Sarepta Therapeutics
SRPT
SRPT
233 hedge funds and large institutions have $2.44B invested in Sarepta Therapeutics in 2017 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 104 increasing their positions, 34 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 189 → 233 (+44)
22% more call options, than puts
Call options by funds: $312M | Put options by funds: $256M
5.81% more ownership
Funds ownership: 77.72% → 83.52% (+5.8%)
Holders
233
Holding in Top 10
6
Calls
$312M
Puts
$256M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$46.8M | |
| 3 | +$45.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$43.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.2M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$36.7M | |
| 3 | -$20.9M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$17.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.2M |